Accesso libero

The Spectrum and Frequency of Cystic Fibrosis Mutations in Albanian Patients

, , ,  e   
06 set 2024
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Genotype variants and their frequency

Genotype variants Frequency number (N=) Percentage %
F508del/F508del 87 75.00
F508del/non F508del 23 19.82
F508del/G85E 4 3.44
F508del/E822X 3 2.58
F508del/621+1G>T 3 2.58
F508del/R1066C 3 2.58
F508del/G1349D 2 1.72
F508del/G542X 2 1.72
F508del/N1303K 2 1.72
F508del/R1070Q 1 0.86
F508del/S466X-R1070Q - in cis 1 0.86
F508del/R1158X 1 0.86
F508del /E831X 1 0.86
non F508del/non F508del 6 5.17
G542X/621+1G>T 1 0.86
G85E/R1158X 1 0.86
G542X/E822X 1 0.86
621+1G>T/621+1G>T 1 0.86
CFTR dele 2.3/1811+1G->C 1 0.86
S466X-R1070Q in cis / E822X 1 0.86

Incidence of Cystic fibrosis in Albania

Time Period Birth Rate in Albania CF cases diagnosed at UHCMT Incidence
1992–2017 1144138 285 1:4014

Overview data about patient with CF in Albania*

Year of follow up 2019 Number (n=) Percentage (%)
No. of patients 133 100
Male 72 54.14
Female 61 45.86

Mean Age (years) at follow up.

(Min-max)

10.5

0.5–28.0

Mean Age (years) at diagnosis.

(Min-max)

0.75

0.0–16.0

No. of patients <18 years 115 86.47
No. of patients > 18 years 18 13.53
Homozygote for F508del 87 65.41
Compound heterozygous mutation F508del 23 17.29
Non-F508 mutation patients 6 4.51
One determined mutation 6 4.51
Unexamined 11 8.27

Mean BMI Z-score: ± SD.

>18 years old

<18 years old

−1.2

−0.7

Mean FEV1 (% predicted) 89.7
Chronic S.aureus 39 29.32
Chronic P.aeruginosae 33 24.8
CF liver disease 54 40.60
CF-related diabetes 6 4.51
Pancreatic sufficient cases 3 2.2

Allele frequencies in 122 Albanian patients and Classes according to their effect on the synthesis and/or function of the CFTR protein_

CFTR gene mutations NM_00492.3 Legacy name, coding DNA, protein name Mutation Type Class of Mutation All Alleles N= 244(%)
F508del, c.1521_1523delCTT, p. Phe508del deletion II 203(83.19)
621+1G>T, c.489+1G>T splicing I 6 (2.45)
E822X, c.2464G>T, p. Glu822Ter nonsense I 5 (2.04)
G85E, c.254G>A, p. Gly85Glu missense II 5 (2.04)
G542X (c.1624G>T) p. Gly542Ter nonsense I 4 (1.63)
R1066C, c.3196C>T, p. Arg1066Cys missense II 3 (1.22)
**R1070Q, c.3209G>A, p. Arg1070Gln missense Unclassified 3 (1.22)
R1158X, c.3472C>T, p. Arg1158Ter nonsense I 2 (0.81)
G1349D, c.4046G>A p. Gly1349Asp missense III 2 (0.81)
N1303K, (c.3909C>G), p. Asn1303Lys missense II 2 (0.81)
**S466X, c.1397C>G, p. Ser466Ter nonsense I 2 (0.81)
1811+1G->C, c.1679+1G>C splicing V 1 (0.40)
E831X, c.2491G>T, p. Glu831X nonsense I 1 (0.40)
CFTRdele2-3(21kb), c.54-5940_273 + 10250 del, p. Ser18Argfs*16 deletion I 1 (0.40)
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Scienze medicali di base, altro